Bio Preventive Medicine Corp.

As of June 30, 2026, Bio Preventive Medicine Corp. carries a market capitalization of 1.14B, placing it among publicly traded companies globally. Its enterprise value stands at 1.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Bio Preventive Medicine Corp. has 49.45M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Bio Preventive Medicine Corp. maintains a current ratio of 12.99, meaning it holds 13.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Bio Preventive Medicine Corp.'s stock has declined approximately 14.58% over the past 52 weeks. The 50-day moving average sits at 21.62, while the 200-day moving average is 22.58.

As of June 30, 2026, Bio Preventive Medicine Corp. holds 198.97M in cash and equivalents against 99.05M in total debt, resulting in a net debt position of -99.92M. Total book value stands at 259.83M, with working capital of 198.32M providing operational flexibility.

Bio Preventive Medicine Corp.'s most recent stock split took place on October 17, 2024 with a 869:966 split ratio.